2013 Q1 Form 10-Q Financial Statement
#000088559013000025 Filed on May 03, 2013
Income Statement
| Concept | 2013 Q1 | 2012 Q1 |
|---|---|---|
| Revenue | $1.068B | $856.1M |
| YoY Change | 24.8% | 51.52% |
| Cost Of Revenue | $284.9M | $224.2M |
| YoY Change | 27.08% | 10.33% |
| Gross Profit | $783.5M | $631.9M |
| YoY Change | 23.99% | 74.66% |
| Gross Profit Margin | 73.33% | 73.81% |
| Selling, General & Admin | $241.9M | $177.3M |
| YoY Change | 36.45% | 27.09% |
| % of Gross Profit | 30.87% | 28.06% |
| Research & Development | $23.80M | $22.01M |
| YoY Change | 8.15% | 60.63% |
| % of Gross Profit | 3.04% | 3.48% |
| Depreciation & Amortization | $341.4M | $215.6M |
| YoY Change | 58.35% | 69.76% |
| % of Gross Profit | 43.57% | 34.12% |
| Operating Expenses | $265.7M | $199.3M |
| YoY Change | 33.32% | -24.85% |
| Operating Profit | $117.0M | $61.50M |
| YoY Change | 90.26% | -36.34% |
| Interest Expense | -$150.4M | -$74.50M |
| YoY Change | 101.88% | 17.51% |
| % of Operating Profit | -128.55% | -121.15% |
| Other Income/Expense, Net | ||
| YoY Change | ||
| Pretax Income | -$54.80M | -$13.18M |
| YoY Change | 315.75% | -525.19% |
| Income Tax | -$27.30M | -$260.0K |
| % Of Pretax Income | ||
| Net Earnings | -$27.50M | $178.7M |
| YoY Change | -115.39% | 2649.08% |
| Net Earnings / Revenue | -2.57% | 20.87% |
| Basic Earnings Per Share | ||
| Diluted Earnings Per Share | -$89.93K | -$41.91K |
| COMMON SHARES | ||
| Basic Shares Outstanding | 305.8M shares | 307.8M shares |
| Diluted Shares Outstanding | 305.8M shares | 307.8M shares |
Balance Sheet
| Concept | 2013 Q1 | 2012 Q1 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $414.0M | $332.0M |
| YoY Change | 24.7% | -18.23% |
| Cash & Equivalents | $413.7M | $330.5M |
| Short-Term Investments | $1.000M | |
| Other Short-Term Assets | $393.0M | $213.0M |
| YoY Change | 84.51% | 77.5% |
| Inventory | $509.7M | $374.0M |
| Prepaid Expenses | ||
| Receivables | $1.054B | $614.0M |
| Other Receivables | $0.00 | $0.00 |
| Total Short-Term Assets | $2.370B | $1.532B |
| YoY Change | 54.71% | 20.16% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $453.0M | $427.0M |
| YoY Change | 6.08% | 38.64% |
| Goodwill | $5.165B | |
| YoY Change | ||
| Intangibles | $9.227B | |
| YoY Change | ||
| Long-Term Investments | ||
| YoY Change | ||
| Other Assets | $180.4M | $122.0M |
| YoY Change | 47.88% | -12.86% |
| Total Long-Term Assets | $15.12B | $12.09B |
| YoY Change | 25.05% | 16.09% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $2.370B | $1.532B |
| Total Long-Term Assets | $15.12B | $12.09B |
| Total Assets | $17.49B | $13.62B |
| YoY Change | 28.39% | 16.53% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $183.0M | $156.0M |
| YoY Change | 17.32% | 34.48% |
| Accrued Expenses | $1.072B | $543.0M |
| YoY Change | 97.35% | 9.92% |
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Long-Term Debt Due | $289.7M | $145.0M |
| YoY Change | 99.78% | 752.94% |
| Total Short-Term Liabilities | $1.646B | $958.0M |
| YoY Change | 71.83% | 44.93% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $10.33B | $6.851B |
| YoY Change | 50.74% | 45.8% |
| Other Long-Term Liabilities | $167.1M | $600.0M |
| YoY Change | -72.15% | 74.93% |
| Total Long-Term Liabilities | $10.49B | $7.451B |
| YoY Change | 40.85% | 47.78% |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $1.646B | $958.0M |
| Total Long-Term Liabilities | $10.49B | $7.451B |
| Total Liabilities | $13.90B | $9.543B |
| YoY Change | 45.65% | 36.74% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | -$2.424B | |
| YoY Change | ||
| Common Stock | $6.208B | |
| YoY Change | ||
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | $3.587B | $4.076B |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $17.49B | $13.62B |
| YoY Change | 28.39% | 16.53% |
Cashflow Statement
| Concept | 2013 Q1 | 2012 Q1 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | -$27.50M | $178.7M |
| YoY Change | -115.39% | 2649.08% |
| Depreciation, Depletion And Amortization | $341.4M | $215.6M |
| YoY Change | 58.35% | 69.76% |
| Cash From Operating Activities | $255.3M | $167.2M |
| YoY Change | 52.69% | 93.74% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | $14.00M | $11.12M |
| YoY Change | 25.94% | -103.43% |
| Acquisitions | $237.6M | $272.8M |
| YoY Change | -12.91% | |
| Other Investing Activities | -$220.2M | -$205.4M |
| YoY Change | 7.21% | -58.99% |
| Cash From Investing Activities | -$234.9M | -$218.4M |
| YoY Change | 7.55% | -73.54% |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | $35.00M | $108.7M |
| YoY Change | -67.81% | |
| Debt Paid & Issued, Net | $430.0M | $302.8M |
| YoY Change | 42.0% | |
| Cash From Financing Activities | -515.9M | 210.4M |
| YoY Change | -345.2% | -71.67% |
| NET CHANGE | ||
| Cash From Operating Activities | 255.3M | 167.2M |
| Cash From Investing Activities | -234.9M | -218.4M |
| Cash From Financing Activities | -515.9M | 210.4M |
| Net Change In Cash | -495.5M | 159.2M |
| YoY Change | -411.24% | 4089.47% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | $255.3M | $167.2M |
| Capital Expenditures | $14.00M | $11.12M |
| Free Cash Flow | $241.3M | $156.1M |
| YoY Change | 54.6% | -62.0% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2013Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
17486467000 | USD |
| CY2013Q1 | us-gaap |
Liabilities
Liabilities
|
13899479000 | USD |
| CY2013Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1646128000 | USD |
| CY2013Q1 | us-gaap |
Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
|
90391000 | USD |
| CY2013Q1 | us-gaap |
Receivables Net Current
ReceivablesNetCurrent
|
1054161000 | USD |
| CY2013Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
303801803 | shares |
| CY2013Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
303801803 | shares |
| CY2012Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
303861272 | shares |
| CY2012Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
303861272 | shares |
| CY2012Q1 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
750880000 | USD |
| CY2012Q1 | us-gaap |
Royalty Revenue
RoyaltyRevenue
|
79231000 | USD |
| CY2012Q1 | us-gaap |
Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
|
25992000 | USD |
| CY2012Q1 | us-gaap |
Revenues
Revenues
|
856103000 | USD |
| CY2012Q1 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
224196000 | USD |
| CY2012Q1 | us-gaap |
Cost Of Services Licenses And Services
CostOfServicesLicensesAndServices
|
87640000 | USD |
| CY2012Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
177286000 | USD |
| CY2012Q1 | us-gaap |
Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
22006000 | USD |
| CY2012Q1 | vrx |
Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold
AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold
|
200643000 | USD |
| CY2012Q1 | us-gaap |
Restructuring Charges
RestructuringCharges
|
62337000 | USD |
| CY2012Q1 | us-gaap |
Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
|
7505000 | USD |
| CY2012Q1 | us-gaap |
Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
|
-3155000 | USD |
| CY2012Q1 | us-gaap |
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset
|
9839000 | USD |
| CY2012Q1 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
794607000 | USD |
| CY2012Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
61496000 | USD |
| CY2012Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
1123000 | USD |
| CY2012Q1 | us-gaap |
Interest And Debt Expense
InterestAndDebtExpense
|
102025000 | USD |
| CY2012Q1 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-133000 | USD |
| CY2012Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
24299000 | USD |
| CY2012Q1 | us-gaap |
Gain Loss On Investments
GainLossOnInvestments
|
2059000 | USD |
| CY2012Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-13181000 | USD |
| CY2012Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-260000 | USD |
| CY2012Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-12921000 | USD |
| CY2012Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
307776000 | shares |
| CY2012Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
307776000 | shares |
| CY2013Q1 | us-gaap |
Revenues
Revenues
|
1068355000 | USD |
| CY2013Q1 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
951349000 | USD |
| CY2013Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
117006000 | USD |
| CY2013Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-54794000 | USD |
| CY2013Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-27530000 | USD |
| CY2012Q1 | us-gaap |
Payments For Legal Settlements
PaymentsForLegalSettlements
|
60000 | USD |
| CY2012Q1 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
196045000 | USD |
| CY2013Q1 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
-83068000 | USD |
| CY2012Q1 | vrx |
Other Comprehensive Income Reclassification Adjustment For Equity Securities Net Of Tax
OtherComprehensiveIncomeReclassificationAdjustmentForEquitySecuritiesNetOfTax
|
1634000 | USD |
| CY2012Q1 | vrx |
Other Comprehensive Income Unrealized Holding Gain Loss On Debt Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnDebtSecuritiesArisingDuringPeriodNetOfTax
|
-13000 | USD |
| CY2012Q1 | us-gaap |
Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
|
123000 | USD |
| CY2012Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
194275000 | USD |
| CY2012Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
181354000 | USD |
| CY2013Q1 | us-gaap |
Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
|
12000 | USD |
| CY2013Q1 | vrx |
Other Comprehensive Income Reclassification Adjustment For Auction Rate Securities Net Of Tax
OtherComprehensiveIncomeReclassificationAdjustmentForAuctionRateSecuritiesNetOfTax
|
1000 | USD |
| CY2013Q1 | vrx |
Other Comprehensive Income Unrealized Holding Gain Loss On Equity Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnEquitySecuritiesArisingDuringPeriodNetOfTax
|
5678000 | USD |
| CY2013Q1 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
9647000 | USD |
| CY2013Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-77403000 | USD |
| CY2013Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-104933000 | USD |
| CY2012Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
215582000 | USD |
| CY2012Q1 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
5747000 | USD |
| CY2012Q1 | vrx |
Acquisition Accounting Adjustment On Inventory Sold
AcquisitionAccountingAdjustmentOnInventorySold
|
33098000 | USD |
| CY2012Q1 | us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
-9527000 | USD |
| CY2012Q1 | vrx |
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash
|
9839000 | USD |
| CY2012Q1 | vrx |
Allowances For Losses On Accounts Receivable And Inventories
AllowancesForLossesOnAccountsReceivableAndInventories
|
4383000 | USD |
| CY2012Q1 | vrx |
Deferred Income Tax Noncash Expense Benefit
DeferredIncomeTaxNoncashExpenseBenefit
|
-14859000 | USD |
| CY2012Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
19152000 | USD |
| CY2012Q1 | us-gaap |
Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
|
593000 | USD |
| CY2013Q1 | vrx |
Payment Of Accreted Interest On Contingent Consideration
PaymentOfAccretedInterestOnContingentConsideration
|
638000 | USD |
| CY2012Q1 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
7613000 | USD |
| CY2012Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
14786000 | USD |
| CY2012Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
35080000 | USD |
| CY2012Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
4266000 | USD |
| CY2012Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-15585000 | USD |
| CY2013Q1 | us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
237603000 | USD |
| CY2012Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
167230000 | USD |
| CY2013Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
255349000 | USD |
| CY2012Q1 | us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
272812000 | USD |
| CY2012Q1 | us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
1865000 | USD |
| CY2012Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
11116000 | USD |
| CY2012Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
|
25564000 | USD |
| CY2013Q1 | us-gaap |
Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
|
1859000 | USD |
| CY2012Q1 | us-gaap |
Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
|
8364000 | USD |
| CY2012Q1 | us-gaap |
Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
|
7200000 | USD |
| CY2012Q1 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
66250000 | USD |
| CY2013Q1 | us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
430036000 | USD |
| CY2012Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-218379000 | USD |
| CY2012Q1 | us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
645643000 | USD |
| CY2012Q1 | us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
302812000 | USD |
| CY2012Q1 | us-gaap |
Proceeds From Short Term Debt
ProceedsFromShortTermDebt
|
7364000 | USD |
| CY2013Q1 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: justify;"> </p> <table style="text-align:left;FONT-SIZE: 10pt; PADDING-BOTTOM: 10px; PADDING-TOP: 10px; FONT-FAMILY: Times New Roman;" cellspacing="0" cellpadding="0"> <tr style="padding:0;"> <td style="WIDTH: 24px;"></td> <td></td></tr> <tr style="padding:0;"> <td style="VERTICAL-ALIGN: top;"> <div style="PADDING-LEFT: 0px; FONT-SIZE: 10pt;"><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: inherit;">1.</font></div></td> <td style="VERTICAL-ALIGN: top;"> <div style="FONT-SIZE: 10pt;"><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: inherit;">DESCRIPTION OF BUSINESS</font></div></td></tr></table> <div style="PADDING-LEFT: 24px; FONT-SIZE: 10pt; PADDING-BOTTOM: 10px; PADDING-TOP: 10px; TEXT-ALIGN: justify;"><font style="FONT-SIZE: 10pt; FONT-FAMILY: inherit;">The Company is a multinational, specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, neurology and branded generics, as well as medical devices.</font></div> <div style="PADDING-LEFT: 24px; FONT-SIZE: 10pt; PADDING-BOTTOM: 10px; PADDING-TOP: 10px; TEXT-ALIGN: justify;"><font style="FONT-SIZE: 10pt; FONT-FAMILY: inherit;">On December 11, 2012, the Company completed the acquisition of Medicis Pharmaceutical Corporation (“Medicis”) through a wholly-owned subsidiary pursuant to an Agreement and Plan of Merger, dated as of September 2, 2012, with Medicis surviving as a wholly-owned subsidiary of the Company (the “Medicis acquisition”).</font></div> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: justify;"> </p> </div> | |
| CY2013Q1 | us-gaap |
Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
|
1417000 | USD |
| CY2012Q1 | us-gaap |
Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
|
3975000 | USD |
| CY2013Q1 | us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
|
-6889000 | USD |
| CY2012Q1 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
108724000 | USD |
| CY2012Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
5108000 | USD |
| CY2012Q1 | us-gaap |
Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
|
593000 | USD |
| CY2012Q1 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
3824000 | USD |
| CY2013Q1 | vrx |
Business Acquisition Cost Of Acquired Entity Liabilities Incurred Contingent Consideration At Fair Value
BusinessAcquisitionCostOfAcquiredEntityLiabilitiesIncurredContingentConsiderationAtFairValue
|
-59064000 | USD |
| CY2012Q1 | vrx |
Payments Of Contingent Consideration
PaymentsOfContingentConsideration
|
27500000 | USD |
| CY2012Q1 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
1435000 | USD |
| CY2012Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
210438000 | USD |
| CY2012Q1 | us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
|
7079000 | USD |
| CY2012Q1 | us-gaap |
Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
|
166368000 | USD |
| CY2013Q1 | us-gaap |
Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
|
-502355000 | USD |
| CY2012Q1 | vrx |
Business Acquisition Cost Of Acquired Entity Liabilities Incurred Contingent Consideration At Fair Value
BusinessAcquisitionCostOfAcquiredEntityLiabilitiesIncurredContingentConsiderationAtFairValue
|
-17744000 | USD |
| CY2013Q1 | dei |
Entity Registrant Name
EntityRegistrantName
|
Valeant Pharmaceuticals International, Inc. | |
| CY2013Q1 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0000885590 | |
| CY2013Q1 | dei |
Document Type
DocumentType
|
10-Q | |
| CY2013Q1 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2013-03-31 | |
| CY2013Q1 | dei |
Amendment Flag
AmendmentFlag
|
false | |
| CY2013Q1 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
| CY2013Q1 | dei |
Entity Filer Category
EntityFilerCategory
|
Large Accelerated Filer | |
| CY2013Q1 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
| CY2013Q1 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2013 | |
| CY2013Q1 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
| CY2013Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
305864659 | shares |
| CY2012Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
916091000 | USD |
| CY2012Q4 | us-gaap |
Receivables Net Current
ReceivablesNetCurrent
|
913835000 | USD |
| CY2012Q4 | us-gaap |
Inventory Net
InventoryNet
|
531256000 | USD |
| CY2012Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
130279000 | USD |
| CY2012Q4 | us-gaap |
Assets Held For Sale Current
AssetsHeldForSaleCurrent
|
90983000 | USD |
| CY2012Q4 | us-gaap |
Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
|
195007000 | USD |
| CY2012Q4 | us-gaap |
Assets Current
AssetsCurrent
|
2777451000 | USD |
| CY2012Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
462724000 | USD |
| CY2011Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
164111000 | USD |
| CY2012Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
9308669000 | USD |
| CY2012Q4 | us-gaap |
Goodwill
Goodwill
|
5141366000 | USD |
| CY2012Q4 | us-gaap |
Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
|
76422000 | USD |
| CY2012Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
183747000 | USD |
| CY2012Q4 | us-gaap |
Assets
Assets
|
17950379000 | USD |
| CY2012Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
227384000 | USD |
| CY2012Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
1008224000 | USD |
| CY2012Q4 | us-gaap |
Business Acquisition Contingent Consideration At Fair Value Current
BusinessAcquisitionContingentConsiderationAtFairValueCurrent
|
102559000 | USD |
| CY2012Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
480182000 | USD |
| CY2012Q4 | us-gaap |
Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
|
4403000 | USD |
| CY2012Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1822752000 | USD |
| CY2012Q4 | us-gaap |
Business Acquisition Contingent Consideration At Fair Value Noncurrent
BusinessAcquisitionContingentConsiderationAtFairValueNoncurrent
|
352523000 | USD |
| CY2012Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
10535443000 | USD |
| CY2012Q4 | us-gaap |
Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
|
103658000 | USD |
| CY2012Q4 | us-gaap |
Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
|
1248312000 | USD |
| CY2012Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
170293000 | USD |
| CY2012Q4 | us-gaap |
Liabilities
Liabilities
|
14232981000 | USD |
| CY2012Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
5940652000 | USD |
| CY2012Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
267118000 | USD |
| CY2012Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-2370976000 | USD |
| CY2012Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-119396000 | USD |
| CY2012Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
3717398000 | USD |
| CY2012Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
17950379000 | USD |
| CY2013Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-2423731000 | USD |
| CY2013Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
413736000 | USD |
| CY2012Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
330479000 | USD |
| CY2013Q1 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
1038867000 | USD |
| CY2013Q1 | us-gaap |
Comparability Of Prior Year Financial Data
ComparabilityOfPriorYearFinancialData
|
<div style="font-size:10.0pt;font-family:Times New Roman;"> <div style="PADDING-LEFT: 24px; FONT-SIZE: 10pt; PADDING-BOTTOM: 10px; PADDING-TOP: 10px; TEXT-ALIGN: justify;"><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: inherit;">Reclassifications and Revision</font></div> <div style="PADDING-LEFT: 24px; FONT-SIZE: 10pt; PADDING-BOTTOM: 10px; PADDING-TOP: 10px; TEXT-ALIGN: justify;"><font style="FONT-SIZE: 10pt; FONT-FAMILY: inherit;">Certain reclassifications have been made to prior year amounts to conform with the current year presentation.</font></div> <div style="PADDING-LEFT: 24px; FONT-SIZE: 10pt; PADDING-BOTTOM: 10px; PADDING-TOP: 10px; TEXT-ALIGN: justify;"><font style="FONT-SIZE: 10pt; FONT-FAMILY: inherit;">The Company has revised the consolidated statement of comprehensive income for the three-month period ended March 31, 2012 to correct the foreign currency translation adjustment, which resulted in an offsetting adjustment to Goodwill and Intangible assets, net. For the three-month period ended March 31, 2012, the Company increased comprehensive income by $21.4 million with an offsetting increase in Goodwill and Intangible assets, net. This revision did not have a material impact to the Company’s previously reported financial position, results of operations or cash flows.</font></div> </div> | |
| CY2013Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="font-size:10.0pt;font-family:Times New Roman;"> <div style="PADDING-LEFT: 24px; FONT-SIZE: 10pt; PADDING-BOTTOM: 10px; PADDING-TOP: 10px; TEXT-ALIGN: justify;"><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: inherit;">Use of Estimates</font></div> <div style="PADDING-LEFT: 24px; FONT-SIZE: 10pt; PADDING-BOTTOM: 10px; PADDING-TOP: 10px; TEXT-ALIGN: justify;"><font style="FONT-SIZE: 10pt; FONT-FAMILY: inherit;">In preparing the unaudited consolidated financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the dates of the unaudited consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates and the operating results for the interim periods presented are not necessarily indicative of the results expected for the full year.</font></div> <div style="PADDING-LEFT: 24px; FONT-SIZE: 10pt; PADDING-BOTTOM: 10px; PADDING-TOP: 10px; TEXT-ALIGN: justify;"><font style="FONT-SIZE: 10pt; FONT-FAMILY: inherit;">On an ongoing basis, management reviews its estimates to ensure that these estimates appropriately reflect changes in the Company’s business and new information as it becomes available. If historical experience and other factors used by management to make these estimates do not reasonably reflect future activity, the Company’s results of operations and financial position could be materially impacted.</font></div> </div> | |
| CY2012Q1 | us-gaap |
Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
|
1167234000 | USD |
| CY2012Q1 | us-gaap |
Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
|
-40663000 | USD |
| CY2013Q1 | us-gaap |
Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
|
1083582000 | USD |
| CY2013Q1 | us-gaap |
Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
|
5017000 | USD |
| CY2013Q1 | vrx |
Business Acquisition Pro Forma Acquisition Accounting Adjustment Of Inventory Sold
BusinessAcquisitionProFormaAcquisitionAccountingAdjustmentOfInventorySold
|
43200000 | USD |
| CY2013Q1 | vrx |
Business Acquisition Pro Forma Acquisition Related Costs
BusinessAcquisitionProFormaAcquisitionRelatedCosts
|
4400000 | USD |
| CY2013Q1 | us-gaap |
Restructuring Charges
RestructuringCharges
|
48985000 | USD |
| CY2013Q1 | us-gaap |
Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
|
35651000 | USD |
| CY2013Q1 | us-gaap |
Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
|
22246000 | USD |
| CY2013Q1 | us-gaap |
Goodwill Translation Adjustments
GoodwillTranslationAdjustments
|
-34016000 | USD |
| CY2013Q1 | us-gaap |
Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
|
4414000 | USD |
| CY2013Q1 | us-gaap |
Available For Sale Securities Fair Value Disclosure
AvailableForSaleSecuritiesFairValueDisclosure
|
10092000 | USD |
| CY2013Q1 | us-gaap |
Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
|
5678000 | USD |
| CY2012Q4 | us-gaap |
Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
|
11197000 | USD |
| CY2012Q4 | us-gaap |
Available For Sale Securities Fair Value Disclosure
AvailableForSaleSecuritiesFairValueDisclosure
|
11577000 | USD |
| CY2012Q4 | us-gaap |
Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
|
380000 | USD |
| CY2012Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
120885000 | USD |
| CY2012Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
60384000 | USD |
| CY2012Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
406018000 | USD |
| CY2012Q4 | us-gaap |
Inventory Gross
InventoryGross
|
587287000 | USD |
| CY2012Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
56031000 | USD |
| CY2013Q1 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
135606000 | USD |
| CY2013Q1 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
67129000 | USD |
| CY2013Q1 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
366453000 | USD |
| CY2013Q1 | us-gaap |
Inventory Gross
InventoryGross
|
569188000 | USD |
| CY2013Q1 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
59512000 | USD |
| CY2013Q1 | us-gaap |
Inventory Net
InventoryNet
|
509676000 | USD |
| CY2012Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
10759419000 | USD |
| CY2012Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
1997626000 | USD |
| CY2012Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
8761793000 | USD |
| CY2013Q1 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
10936585000 | USD |
| CY2013Q1 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
2264650000 | USD |
| CY2013Q1 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
8671935000 | USD |
| CY2013Q1 | us-gaap |
Business Acquisition Purchase Price Allocation Intangible Assets Not Amortizable
BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsNotAmortizable
|
555386000 | USD |
| CY2013Q1 | vrx |
Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
|
11491971000 | USD |
| CY2013Q1 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
9227321000 | USD |
| CY2012Q4 | us-gaap |
Business Acquisition Purchase Price Allocation Intangible Assets Not Amortizable
BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsNotAmortizable
|
546876000 | USD |
| CY2012Q4 | vrx |
Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
|
11306295000 | USD |
| CY2013Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
326175000 | USD |
| CY2012Q1 | us-gaap |
Cost Of Goods Sold Amortization
CostOfGoodsSoldAmortization
|
2026000 | USD |
| CY2012Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
202669000 | USD |
| CY2013Q1 | vrx |
Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold
AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold
|
326175000 | USD |
| CY2013Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
|
1156545000 | USD |
| CY2013Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
1088490000 | USD |
| CY2013Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
1058227000 | USD |
| CY2013Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
1005899000 | USD |
| CY2013Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
|
976289000 | USD |
| CY2013Q1 | us-gaap |
Goodwill
Goodwill
|
5165247000 | USD |
| CY2012Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
11015625000 | USD |
| CY2013Q1 | us-gaap |
Long Term Debt
LongTermDebt
|
10617120000 | USD |
| CY2013Q1 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
289676000 | USD |
| CY2013Q1 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
10327444000 | USD |
| CY2012Q4 | us-gaap |
Long Term Debt Fair Value
LongTermDebtFairValue
|
11700000000 | USD |
| CY2013Q1 | us-gaap |
Long Term Debt Fair Value
LongTermDebtFairValue
|
11200000000 | USD |
| CY2012Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
19152000 | USD |
| CY2013Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
9095000 | USD |
| CY2013Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P2Y4M24D | |
| CY2013Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
102100000 | USD |
| CY2013Q1 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-196799000 | USD |
| CY2013Q1 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-83068000 | USD |
| CY2013Q1 | us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax
|
-1000 | USD |
| CY2013Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
5678000 | USD |
| CY2013Q1 | us-gaap |
Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
|
-12000 | USD |
| CY2013Q1 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
124500000 | USD |
| CY2013Q1 | vrx |
Unrecognized Tax Benefits Including Interest And Penalties
UnrecognizedTaxBenefitsIncludingInterestAndPenalties
|
132400000 | USD |
| CY2013Q1 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
|
24900000 | USD |
| CY2013Q1 | us-gaap |
Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
|
93000000 | USD |
| CY2013Q1 | us-gaap |
Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
|
500000 | USD |
| CY2013Q1 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued
|
100000 | USD |
| CY2013Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
305763000 | shares |
| CY2013Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
305763000 | shares |
| CY2012Q1 | vrx |
Potential Weighted Average Number Of Diluted Shares Outstanding
PotentialWeightedAverageNumberOfDilutedSharesOutstanding
|
316397000 | shares |
| CY2013Q1 | vrx |
Potential Weighted Average Number Of Diluted Shares Outstanding
PotentialWeightedAverageNumberOfDilutedSharesOutstanding
|
312350000 | shares |
| CY2013Q1 | us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
2 | item |
| CY2012Q1 | us-gaap |
Profit Loss
ProfitLoss
|
178690000 | USD |
| CY2013Q1 | us-gaap |
Profit Loss
ProfitLoss
|
213810000 | USD |
| CY2013Q1 | us-gaap |
Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
|
7899000 | USD |
| CY2013Q1 | us-gaap |
Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
|
-4448000 | USD |
| CY2013Q1 | us-gaap |
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset
|
-2185000 | USD |
| CY2013Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
1596000 | USD |
| CY2013Q1 | us-gaap |
Interest And Debt Expense
InterestAndDebtExpense
|
155315000 | USD |
| CY2013Q1 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-21379000 | USD |
| CY2013Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
1439000 | USD |
| CY2013Q1 | us-gaap |
Gain Loss On Investments
GainLossOnInvestments
|
1859000 | USD |
| CY2011Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
3929830000 | USD |
| CY2012Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
4020618000 | USD |
| CY2012Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
3717398000 | USD |
| CY2012Q1 | vrx |
Repurchase Of Equity Component Of Convertible Debt
RepurchaseOfEquityComponentOfConvertibleDebt
|
2862000 | USD |
| CY2012Q1 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
5099000 | USD |
| CY2012Q1 | us-gaap |
Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
|
108724000 | USD |
| CY2012Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
19152000 | USD |
| CY2013Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
9095000 | USD |
| CY2013Q1 | us-gaap |
Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
|
35005000 | USD |
| CY2012Q1 | us-gaap |
Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
|
-3824000 | USD |
| CY2013Q1 | us-gaap |
Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
|
-6848000 | USD |
| CY2012Q1 | us-gaap |
Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
|
593000 | USD |
| CY2013Q1 | us-gaap |
Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
|
4604000 | USD |
| CY2012Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
194275000 | USD |
| CY2012Q1 | us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
181354000 | USD |
| CY2013Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-77403000 | USD |
| CY2013Q1 | us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
-104933000 | USD |
| CY2013Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
3586988000 | USD |
| CY2013Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0 | |
| CY2012Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0 | |
| CY2012Q1 | vrx |
Stockholders Equity Before Comprehensive Income Net Of Tax
StockholdersEquityBeforeComprehensiveIncomeNetOfTax
|
3839264000 | USD |
| CY2013Q1 | vrx |
Stockholders Equity Before Comprehensive Income Net Of Tax
StockholdersEquityBeforeComprehensiveIncomeNetOfTax
|
3691921000 | USD |
| CY2013Q1 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
2677000 | USD |
| CY2013Q1 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
35005000 | USD |
| CY2013Q1 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
136747000 | USD |
| CY2013Q1 | us-gaap |
Assets Held For Sale Current
AssetsHeldForSaleCurrent
|
56930000 | USD |
| CY2013Q1 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
180410000 | USD |
| CY2013Q1 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
264982000 | USD |
| CY2013Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2012Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2013Q1 | us-gaap |
Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
|
0 | USD |
| CY2013Q1 | vrx |
Business Acquisition Pro Forma Earnings Per Share Basic And Diluted
BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted
|
0.02 | |
| CY2012Q1 | vrx |
Business Acquisition Pro Forma Earnings Per Share Basic And Diluted
BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted
|
-0.13 | |
| CY2013Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-27264000 | USD |
| CY2012Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
124500000 | USD |
| CY2013Q1 | us-gaap |
Assets
Assets
|
17486467000 | USD |
| CY2013Q1 | us-gaap |
Deferred Tax Assets Liabilities Net Current
DeferredTaxAssetsLiabilitiesNetCurrent
|
198879000 | USD |
| CY2013Q1 | us-gaap |
Assets Current
AssetsCurrent
|
2370129000 | USD |
| CY2013Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
452969000 | USD |
| CY2013Q1 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
183021000 | USD |
| CY2013Q1 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
1071623000 | USD |
| CY2013Q1 | us-gaap |
Business Acquisition Contingent Consideration At Fair Value Current
BusinessAcquisitionContingentConsiderationAtFairValueCurrent
|
97517000 | USD |
| CY2013Q1 | us-gaap |
Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
|
4291000 | USD |
| CY2013Q1 | us-gaap |
Business Acquisition Contingent Consideration At Fair Value Noncurrent
BusinessAcquisitionContingentConsiderationAtFairValueNoncurrent
|
391908000 | USD |
| CY2013Q1 | us-gaap |
Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
|
107020000 | USD |
| CY2013Q1 | us-gaap |
Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
|
1259900000 | USD |
| CY2013Q1 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
167079000 | USD |
| CY2013Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
5942536000 | USD |
| CY2013Q1 | us-gaap |
Royalty Revenue
RoyaltyRevenue
|
9258000 | USD |
| CY2013Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
3586988000 | USD |
| CY2013Q1 | us-gaap |
Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
|
20230000 | USD |
| CY2013Q1 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
284904000 | USD |
| CY2013Q1 | us-gaap |
Cost Of Services Licenses And Services
CostOfServicesLicensesAndServices
|
15429000 | USD |
| CY2013Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
241899000 | USD |
| CY2013Q1 | us-gaap |
Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
23795000 | USD |
| CY2013Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
341445000 | USD |
| CY2013Q1 | vrx |
Acquisition Accounting Adjustment On Inventory Sold
AcquisitionAccountingAdjustmentOnInventorySold
|
43241000 | USD |
| CY2013Q1 | vrx |
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash
|
-2185000 | USD |
| CY2013Q1 | vrx |
Allowances For Losses On Accounts Receivable And Inventories
AllowancesForLossesOnAccountsReceivableAndInventories
|
8994000 | USD |
| CY2013Q1 | vrx |
Deferred Income Tax Noncash Expense Benefit
DeferredIncomeTaxNoncashExpenseBenefit
|
-37355000 | USD |
| CY2013Q1 | us-gaap |
Payments For Legal Settlements
PaymentsForLegalSettlements
|
2820000 | USD |
| CY2013Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
9095000 | USD |
| CY2013Q1 | us-gaap |
Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
|
4604000 | USD |
| CY2013Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
|
1770000 | USD |
| CY2012Q1 | us-gaap |
Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
|
2059000 | USD |
| CY2013Q1 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
-965000 | USD |
| CY2013Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
89227000 | USD |
| CY2013Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
24948000 | USD |
| CY2013Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
122000 | USD |
| CY2013Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
9193000 | USD |
| CY2013Q1 | us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
707000 | USD |
| CY2013Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
14042000 | USD |
| CY2013Q1 | us-gaap |
Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
|
9027000 | USD |
| CY2013Q1 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
8429000 | USD |
| CY2013Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-234896000 | USD |
| CY2013Q1 | us-gaap |
Proceeds From Short Term Debt
ProceedsFromShortTermDebt
|
4471000 | USD |
| CY2013Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
2677000 | USD |
| CY2013Q1 | us-gaap |
Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
|
4604000 | USD |
| CY2013Q1 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
6848000 | USD |
| CY2013Q1 | vrx |
Payments Of Contingent Consideration
PaymentsOfContingentConsideration
|
21054000 | USD |
| CY2013Q1 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
33311000 | USD |
| CY2013Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
-515919000 | USD |
